Effects of Renin-Angiotensin Inhibition on ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Protease Serine 2) Expression: Insights Into COVID-19

Hypertension. 2020 Oct;76(4):e29-e30. doi: 10.1161/HYPERTENSIONAHA.120.15782. Epub 2020 Jul 14.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Angiotensin II Type 2 Receptor Blockers / pharmacology
  • Angiotensin-Converting Enzyme 2
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Animals
  • Betacoronavirus / physiology*
  • COVID-19
  • Coronavirus Infections* / metabolism
  • Coronavirus Infections* / virology
  • Enalapril / pharmacology*
  • Losartan / pharmacology*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Pandemics*
  • Peptidyl-Dipeptidase A* / genetics
  • Peptidyl-Dipeptidase A* / metabolism
  • Pneumonia, Viral* / metabolism
  • Pneumonia, Viral* / virology
  • RNA, Messenger / analysis
  • SARS-CoV-2
  • Serine Endopeptidases* / genetics
  • Serine Endopeptidases* / metabolism
  • Tissue Distribution

Substances

  • Angiotensin II Type 2 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • RNA, Messenger
  • Enalapril
  • Peptidyl-Dipeptidase A
  • Ace2 protein, mouse
  • Angiotensin-Converting Enzyme 2
  • Serine Endopeptidases
  • TMPRSS2 protein, mouse
  • Losartan